Literature DB >> 25547440

Towards a pragmatic and operational definition of relapse in schizophrenia: A Delphi consensus approach.

Luis San1, Manuel Serrano, Fernando Cañas, Samuel Leopoldo Romero, Ángeles Sánchez-Cabezudo, Mariano Villar.   

Abstract

OBJECTIVE: To develop pragmatic and operational definitions of relapse in schizophrenia.
METHODS: A two-round Delphi consensus approach was used. The final questionnaire based on seven pre-established definition relapse models developed by a panel of eight experts was presented to 33 general psychiatrists who attended an "ad hoc" meeting.
RESULTS: The most frequent components of the pragmatic definition were the psychopathological severity of the psychotic spectrum (70%), more intense management of the case (68%), a previously stabilized episode (67%), and impairment in functioning and social behavior (67%). In the operational definition, reappearance of symptoms was considered indispensable by 71% of the participants, and reappearance of positive symptoms measured by clinical scales was considered recommendable by 67%. Between 46% and 53% rated worsening of severity status and worsening of functioning as indispensable or recommendable. An increase of ≥ 10 points in the positive subscale of Positive and Negative Symptom Scale was rated by 51% of the participants, a score of 6 points in the Clinical Global Impression scale (much worse) by 89%, and a reduction of ≥ 20 points in the Global Assessment of Functioning scale by 62%.
CONCLUSIONS: A better understanding of the definition of relapse in schizophrenia is necessary to improve effective prevention strategies.

Entities:  

Keywords:  Schizophrenia; relapse; treatment outcome

Mesh:

Year:  2015        PMID: 25547440     DOI: 10.3109/13651501.2014.1002501

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  7 in total

1.  Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study.

Authors:  Pierre-Michel Llorca; Philippe Nuss; Éric Fakra; Isabelle Alamome; Dominique Drapier; Wissam El Hage; Renaud Jardri; Stéphane Mouchabac; Marc Rabbani; Nicolas Simon; Marie-Noëlle Vacheron; Jean-Michel Azorin
Journal:  BMC Psychiatry       Date:  2022-05-28       Impact factor: 4.144

2.  Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.

Authors:  Dee Lin; Philippe Thompson-Leduc; Isabelle Ghelerter; Ha Nguyen; Marie-Hélène Lafeuille; Carmela Benson; Panagiotis Mavros; Patrick Lefebvre
Journal:  CNS Drugs       Date:  2021-04-28       Impact factor: 5.749

Review 3.  Fear of relapse in schizophrenia: a mixed-methods systematic review.

Authors:  Stephanie Allan; Andrew Gumley; Zofia Zukowska; Emily Eisner; Li Ling
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-02-13       Impact factor: 4.519

4.  Consensus Definition of Misophonia: A Delphi Study.

Authors:  Susan E Swedo; David M Baguley; Damiaan Denys; Laura J Dixon; Mercede Erfanian; Alessandra Fioretti; Pawel J Jastreboff; Sukhbinder Kumar; M Zachary Rosenthal; Romke Rouw; Daniela Schiller; Julia Simner; Eric A Storch; Steven Taylor; Kathy R Vander Werff; Cara M Altimus; Sylvina M Raver
Journal:  Front Neurosci       Date:  2022-03-17       Impact factor: 4.677

5.  Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study.

Authors:  Cristiana Montemagni; Elisa Del Favero; Elena Cocuzza; Flavio Vischia; Paola Rocca
Journal:  Ther Adv Psychopharmacol       Date:  2022-10-08

6.  Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework.

Authors:  Sandra M Eldridge; Gillian A Lancaster; Michael J Campbell; Lehana Thabane; Sally Hopewell; Claire L Coleman; Christine M Bond
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

7.  Defining Treatment Response, Remission, Relapse, and Recovery in First-Episode Psychosis: A Survey among Korean Experts.

Authors:  Bong Ju Lee; Sung-Wan Kim; Jung Jin Kim; Je-Chun Yu; Kyu Young Lee; Seung-Hee Won; Seung-Hwan Lee; Seung-Hyun Kim; Shi Hyun Kang; Euitae Kim; Kunhyung Kim; Yang Hong Piao; Young-Chul Chung
Journal:  Psychiatry Investig       Date:  2020-02-25       Impact factor: 2.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.